Clifford Chance, has launched a new innovation lab in Singapore, named Create+65, to identify, incubate, test and pilot new legal technology solutions.

Create+65 was designed to bring together venture capitalists, start-ups, product owners and developers, universities and private institutions with the goal of developing and testing new legal services tools and solutions.

Subject to their position in the innovation cycle, participants that join Create+65 would have access to insights from the firm and its clients about technology solutions that target the delivery of legal services as well as feedback and mentoring, data sets and connection to potential investment and/or funding vehicles.

Users would also have access to workspaces and gain the ability to partner with Clifford Chance to develop innovative legal technology solutions.

The firm has shown a drive to lead in tech this year. In April, it launched ‘Clifford Chance's Tech Academy’, a global training programme dedicated to learning and development in the tech space. Meanwhile, in December, along with Latham & Watkins, the firm invested in Reynen Court, a tech venture sometimes called the app Store for legal tech.

The latest initiative is supported by the Singapore Economic Development Board (EDB) and in collaboration with Future Law Innovation Programme (FLIP) by the Singapore Academy of Law (SAL).

 

To contact the editorial team, please email ALBEditor@thomsonreuters.com.

Related Articles

CC, Paul Hastings lead on CR Beverages’ HK IPO

by Charlie Wu 吴卓言 |

Clifford Chance and Jingtian & Gongcheng are advising China Resources Beverages, the beverage division of the state-owned China Resources Enterprise, on its upcoming Hong Kong IPO, which is expected to raise up to $1 billion. Paul Hastings and Zhong Lun Law Firm are acting for the joint sponsors.

Haiwen, CC advise on China TCM's $2 bln take-private deal

Sinopharm Group, an investment consortium led by Sinopharm Group, and China Traditional Chinese Medicine Holdings (China TCM) recently announced a take-private deal for the Hong Kong-listed China TCM through a scheme of arrangement.

CC, Davis Polk act on ChaPanda’s $330 mln Hong Kong IPO

by Charlie Wu 吴卓言 |

Davis Polk & Wardwell and Jingtian & Gongcheng have advised Sichuan Baicha Baidao, a Chinese low-priced tea chain also known as ChaPanda, on its $330 million IPO on the Hong Kong Stock Exchange, with Clifford Chance and King & Wood Mallesons acting for the sponsor CICC and underwriters.